Document Type
Article
Publication Date
10-3-2019
ISSN
0028-4793
Publisher
Massachusetts Medical Society
Language
en-US
Abstract
A new Maryland law that creates a prescription-drug affordability board to help the state regulate drug prices may be a harbinger of what’s to come in drug-pricing legislation. The law permits cost reviews when drug prices or price increases exceed specified thresholds. Establishing affordability boards may be a natural next step that more states take to exert a stronger influence over price spikes and still survive legal challenges.
Recommended Citation
Tara Sklar & Christopher Robertson,
Affordability Boards: The States’ New Fix for Drug Pricing
,
in
381
New England Journal of Medicine
1301
(2019).
Available at:
https://scholarship.law.bu.edu/faculty_scholarship/962
Comments
From The New England Journal of Medicine, Tara Sklar and Christopher T. Robertson, Affordability Boards: The States’ New Fix for Drug Pricing, Volume 381, Page 1301 Copyright © (2019) Massachusetts Medical Society. Reprinted with permission. https://www.nejm.org/author-center/permissions